Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$3.54M Sell
106,100
-6,900
-6% -$239K 0.06% 144
2017
Q1
$4.08M Sell
113,000
-9,855
-8% -$363K 0.07% 137
2016
Q4
$4.25M Sell
122,855
-2,955
-2% -$95.9K 0.08% 127
2016
Q3
$4.26M Sell
125,810
-5,290
-4% -$175K 0.08% 132
2016
Q2
$4.41M Buy
131,100
+75,475
+136% +$2.4M 0.09% 124
2016
Q1
$1.65M Buy
55,625
+3,075
+6% +$83.4K 0.03% 219
2015
Q4
$2.07M Buy
52,550
+1,970
+4% +$74.4K 0.04% 194
2015
Q3
$1.93M Sell
50,580
-22,000
-30% -$1.12M 0.04% 200
2015
Q2
$5.18M Buy
72,580
+32,275
+80% +$2.39M 0.09% 127
2015
Q1
$2.95M Buy
40,305
+3,505
+10% +$266K 0.05% 168
2014
Q4
$2.7M Buy
36,800
+1,740
+5% +$111K 0.05% 171
2014
Q3
$2.07M Buy
35,060
+735
+2% +$45K 0.04% 191
2014
Q2
$2.21M Sell
34,325
-3,375
-9% -$192K 0.04% 199
2014
Q1
$1.85M Buy
+37,700
New +$1.75M 0.03% 211

Other funds holding MPLX

Geneva Advisors's MPLX Position: Q2 2017 in Review

Geneva Advisors reduced its MPLX (MPLX) stake by 6.1% in Q2 2017, selling an estimated $239K and leaving 106,100 shares worth $3.54M. The position accounts for 0.06% of the portfolio, ranked #144.

Geneva Advisors first reported a position in MPLX in Q1 2014 and has held it in 14 quarters since. The position peaked at $5.18M in Q2 2015. 304 funds tracked by Wall St. Rank hold MPLX as of Q2 2017.

  • Geneva Advisors held 106,100 shares of MPLX worth $3.54M as of Q2 2017.
  • Geneva Advisors sold 6,900 MPLX shares in Q2 2017, an estimated $239K.
  • MPLX made up 0.06% of Geneva Advisors's portfolio in Q2 2017, its #144 holding.
  • Geneva Advisors first reported a position in MPLX in Q1 2014 and has held it in 14 quarters since.
  • Geneva Advisors's MPLX position peaked at $5.18M in Q2 2015.
  • 304 funds tracked by Wall St. Rank held MPLX as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.